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The remodeling of the embryonic avian cardiac outflow tract (OFT) involves the removal of cardiomyocytes by programmed cell death
(PCD). In contrast, the prevalence of PCD is low in the atrial or ventricular myocytes during this period of development. To determine if this
selective PCD is due to the unique ability of the OFT cardiomyocytes to execute PCD, we transduced the embryonic chicken heart in ovo
with recombinant adenovirus expressing a death (FasL) ligand. This resulted in programmed cell death in atrial, ventricular, and OFT
cardiomyocytes as evidenced by chromosomal fragmentation, accumulation of lysosomes, and Caspase enzymatic activity. Consistent with
the widespread induction of PCD, transcripts for the Fas receptor were detected in all chambers of the heart throughout development. The
precocious and widespread activation of PCD in the OFT myocardium resulted in a marked dimunition of the subpulmonic myocardial
infundibulum, and transposition of the aorta side-by-side with the pulmonary artery and connecting to the right ventricle. Defects in other
cardiac structures are also described. We conclude that the regulated removal of OFT cardiomyocytes by PCD is required for the great vessels
to make their proper connections with the ventricles in the transition to a dual circulation. The malalignment of the great vessels described in
this animal model are similar to those described in congenital human conotruncal heart defects, suggesting that PCD-dependent remodeling
of the OFT myocardium could be a target of genetic mutations or teratogens that cause human conotruncal heart defects.
D 2004 Elsevier Inc. All rights reserved.Keywords: Apoptosis; Cardiomyocyte; Outflow tract; Death ligandsIntroduction
The embryonic cardiac outflow tract (OFT) connects the
developing ventricles to the aortic sac. In birds and mam-
mals, the OFT myocardium is added from a ‘secondary
(anterior) heart forming field’ from splanchnic mesoderm
beneath the caudal pharynx, well after the formation of the
primitive heart tube from the primary heart forming field
(Kelly et al., 2001; Mjaatvedt et al., 2001; Waldo et al.,
2001). In the subsequent transition to a dual circulation, the
OFT undergoes complex remodeling (reviewed in Pexieder,
1995; Webb et al., 2003). We and others have demonstrated
that the elimination of OFT cardiomyocytes by programmed
cell death (PCD) is involved in the remodeling of the avian0012-1606/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2003.11.020
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1998, 2001). We have used several indicators of PCD,
including chromosomal fragmentation (TUNEL), membrane
binding of AnnexinV, lyosomal markers (LysotrackerRed,
LTR), and activation of Caspase enzymes, to show the PCD
of OFT cardiomyocytes between stages 23 (ED4) and 32
(ED9) of chicken development. At its peak at stages 30–31,
as many as 50% of the cardiomyocytes in certain regions of
the OFT undergo PCD (Watanabe et al., 1998). Fate
analyses of OFT cardiomyocytes transduced with recombi-
nant adenoviral expressing LacZ or green fluorescent pro-
tein (GFP) tags suggested that the remaining OFT
cardiomyocytes reside within the myocardial infundibular
connection of the right ventricle to the pulmonary artery in a
position anterior and to the right of the direct connection of
the aorta to the left ventricle (Watanabe et al., 1998, 2001).
In the current study, we addressed two questions regard-
ing PCD and the development of the embryonic chick heart.
First, is the selective high prevalence of PCD in the OFT
cardiomyocytes due to their unique ability to execute the
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To examine this question, we used recombinant adenovirus
to force the expression of the Fas (death) ligand in stages
15–25 embryonic cardiomyocytes in ovo. We found that
cardiomyocytes in all chambers of the embryonic heart are
competent to execute extrinsic (ligand-dependent) PCD, and
that PCD can be precociously activated in the OFT cardi-
omyocytes. Second, what is the morphogenic role of the
stage-dependent and spatially restricted removal of OFT
cardiomyocytes by PCD? To examine this question, we
targeted FasL to the OFT cardiomyocytes. This resulted in
precocious and widespread PCD in these cells. In a subset of
embryos in which FasL expression was forced, the myocar-
dial subpulmonic infundibulum was absent or greatly re-
duced, and there was a failure of the posterior rotation of the
aorta resulting in DORV morphology with transposition of
the aorta. These results support a model in which the
regulated removal of OFT cardiomyocytes by PCD is
necessary for the formation of the subpulmonic myocardial
infundibulum and the rotation of the aorta to a posterior
position in the transition of the embryo to a dual circulation.Methods
Delivery of recombinant adenovirus
Fertile White Leghorn (Gallus gallus) chicken eggs were
obtained from Squire Valleevue Farm (Cleveland, OH).
Eggs were incubated in a humidified room air incubator at
38jC until the embryos grew to appropriate stages for each
experiment (generally ED3–4). Recombinant replication-
defective adenovirus (approximately 108 pfu) were injected
into the pericardial space of HH stages 15–18 (ED3–4)
(Hamburger and Hamilton, 1951) chicken embryos in ovo
as previously described (Fisher and Watanabe, 1996). Sev-
eral recombinant adenoviruses were used. One provided by
the Pittsburgh Experimental Gene Therapy (PEGT) vector
core expressed FasL throughout the heart, and will be called
AdFasL1. A second recombinant adenovirus was used that
expresses a 943-bp cDNA of murine fasL driven by the
CMV promoter/enhancer (generously provided by Drs. K.
Walsh and Masa Sata (Sata et al., 1998)), so that expression
in this system is restricted to the OFT cardiomyocytes, and
will be called AdFasL2. A recombinant adenovirus that
expresses GFP under the control of the CMV promoter
(AdCMVGFP) was used as a negative control. After injec-
tion, the eggs were incubated in humidified room air for an
additional 8 h to 6 days (stage 35).
Assays for programmed cell death
Embryos were harvested 8–48 h after recombinant
adenovirus injection and assayed for indicators of apoptosis
as previously described (reviewed in (Watanabe et al.,
2002). The accumulation of LysoTracker Red (LTR; Mo-lecular Probes, Eugene, OR) in lysosomes has been previ-
ously shown to be a sensitive and specific indicator of PCD
(Zucker et al., 1998). Comparison of TUNEL and LTR
staining of chick embryo hearts in the same section revealed
co-localization with LTR staining more sensitive in detect-
ing apoptosis (Schaeffer et al., in press). For the LTR assay,
embryos were removed from the egg, dissected to expose
the heart, and incubated in LTR containing solution (2.5
AM) for 15 min at room temperature (22jC) while rocking,
followed by several washings in PBS. The embryos were
fixed in formalin solution (10%, Ted Pella, Inc., Redding,
CA) washed extensively with PBS, and photographed in
whole mount or paraffin-embedded and sectioned in a
sagittal plane. For the TUNEL assay, the embryos were
fixed in 10% neutral buffered formalin, paraffin embedded,
and sectioned in a sagittal plane. The 7-Am serial sections
were stained using the TUNEL technique per manufactur-
er’s instructions (Intergen/Oncor ApopTag Peroxidase Kit).
Caspase activities were measured in homogenates of
pooled atrial, ventricular, or OFT tissues as previously
described (Watanabe et al., 1998) with minor modifica-
tions. Caspase activities were also measured in whole
heart homogenates 8–48 h after adenoviral transduction
(stages 18–24). Tissues were dissected and immediately
triturated in lysis buffer (100 mM HEPES, pH 7.5, 10%
sucrose, 0.1% CHAPS, 1 mM PMSF, 10 Ag/ml pepstatin,
10 Ag/ml leupeptin, and 1 mM EDTA, 10 mM DTT), left
on ice for 30 min, sonicated (Heart System sonicator, 10 s,
10% pulse), centrifuged to remove insoluble proteins
(10,000  g, 10 min, 4jC), and stored at 20jC. Twenty
micrograms of protein was assayed for Caspase activity in
a fluorogenic assay by incubation at 30jC with the
reaction mix containing 100 mM HEPES, pH 7.5, 10%
sucrose, 0.1% Chaps, 1 mM EDTA, 1 mM PMSF, 10 Ag/
ml leupeptin, and with 20 AM of the one of the fluoro-
genic peptide substrates (DEVD-AFC/Caspase-3,7 sub-
strate, IETD-AFC/Caspase-8, Granzyme substrate, or
LEHD-AFC/Caspase-9 substrate; Calbiochem, San Diego,
CA) in a total volume of 0.1 ml. Substrate cleavage occurs
after the terminal Asp and is followed fluorimetrically
with excitation at 400 nm and emission at 505 nm in a
Tecan Spectra FluorPlus fluorescence plate reader. Reac-
tions were sampled hourly for up to 5 h. Activity is
reported for those samples that showed linear increases in
free AFC over time. Activity is normalized to a free AFC
standard curve. Measured fluorescence was linearly related
to the concentration of free AFC with R2 = 0.99.
Analysis of Fas expression by in situ hybridization and
RT-PCR
Expression of Fas transcripts was examined by in situ
hybridization of stages 23–32 chicken embryo by standard
methods. In brief, embryos were fixed in fresh 4% parafor-
maldehyde for 4–16 h depending on the stage, washed in
PBS, dehydrated in a series of graded methanol, and
Fig. 1. Fas transcripts are ubiquitously expressed in the chick embryo. Expression of Fas was examined in stages 23–32 chick embryos by in situ hybridization
as described in Methods. Shown are representative images from stage 30 chick embryo sections hybridized with (A) antisense and (B) sense probes against Fas.
(C) Antisense and (D) sense probes against muscle-specific TroponinT were used in adjacent sections to delineate the myocardium. Signals were detected with
TSA amplification and a Cy3-conjugated secondary antibody (NEN). Images were captured at identical exposures with a Leica DMT microscope and Spot RT
digital camera. Scale bar = 0.5 mm. at = atria; v = ventricle; oft = outflow tract; TnT = TroponinT.
Fig. 2. Detection of Fas transcripts by RT-PCR in outflow tract, atrial, and
ventricular tissues. Total RNA from OFT, atrial, and ventricular tissues was
subjected to RT-PCR for Fas and internal control GAPDH transcripts.
Products were separated by 2% agarose gel electrophoresis and bands
detected with ethidium bromide staining. Two bands were detected in the
Fas RT-PCR reaction. The minor band lacks an alternative exon and codes
for the secreted form of Fas. It is present at a constant ratio of 1:24.
D. Sallee et al. / Developmental Biology 267 (2004) 309–319 311processed immediately or stored at 80jC. Embryos were
rehydrated in a graded methanol series and taken through a
series of sucrose solutions in DEPC treated PBS (12%
sucrose, 15% sucrose, and 20% sucrose) and then in 20%
sucrose overnight. Embryos were cryosectioned at 10-Am
thickness, dried, and stored at 80jC. Sections were
digested with Proteinase K (1 Ag/ml, V5 min at RT) for
variable times depending on the stage. Prehybridization and
probe hybridization were done in UltraHyb (Ambion) with
50% formamide, the latter overnight at 42jC. Digoxigenin-
labeled sense and antisense probes were generated by in
vitro transcription (Roche RNA Labelling kit) per manufac-
turer’s instructions, followed by alkaline hydrolysis to
achieve probes of 150–250 nt. For Fas, sense (5V-
CTTCTCGGTGTGAACATTGCG-3V) and antisense (5V-
GCTGGTGGGTCAGGTCAACATC-3V) oligonucleotide
primers were derived from an EST sequence and used to
amplify an approximately 500 nt cDNA that was subcloned
into a TOPO TA vector (Invitrogen). The identity of the
cDNA was confirmed by sequencing. A chicken cardiac
TroponinT cDNA was generously provided by Dr. P. Antin.
Antisense transcripts from this cDNA were used as a
positive control to specifically identify the myocardium.Probes were titrated to optimize signal and binding was
detected with TSA amplification (NEN) per manufacturer’s
instructions. Images were captured with a Leica DMT
microscope and Spot RT digital camera. Pictures of signals
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exposures. Fas transcripts were also examined by RT-PCR
of stages 23–32 OFT, atrial, and ventricular total RNA by
standard methods using the oligonucleotide primers listed
above. RT-PCR of GAPDH transcripts served as an internal
control.
Analyses of heart morphology
Embryos were fixed in 10% formalin and photographed
as whole mounts with a Leica MZ FLIII stereomicroscope
and Spot RT digital camera. For histological analysis, the
embryos were embedded in paraffin, serial-sectioned at 7
Am in a frontal plane, and stained with hematoxylin and
eosin. Observations were made and photographs were taken
using a Leica DMLB fluorescent microscope. Images were
imported and optimized in Adobe Photoshop 6.0.Results
Analysis of Fas expression
We used in situ hybridization to examine the pattern of
expression of the (Fas) receptor for the Fas death ligand.
Analyses of embryos from stage 23 to 32 of developmentFig. 3. Forced expression of FasL triggers PCD in the embryonic chick heart. AdF
Control embryos received AdGFP. PCD was assayed 8–48 h after adenovirus deli
embryos in (A) whole mount and (D) section, few LTR particles are present at
transduced with AdFasL, numerous LTR particles are present in the (B) OFT, (C,
within the compact layer of the myocardium. The arrow in (B) points to the sharp b
pericardial space beyond which the virus did not infect with the injection protocol.
= 0.5 mm for A–C; Scale bar in D = 0.5 mm for D–F.showed that the Fas transcript was expressed in a non-
tissue-specific manner. An antisense probe to Fas detected
transcripts in myocardial and nonmyocardial compartments
of the heart throughout these stages of development (Fig. 1
and data not shown). The sense probe resulted in no signal,
indicating the specificity of the signal for Fas. An antisense
probe against cardiac TroponinT yielded signal as expected
only in the myocardium of the heart, while the sense probe
yielded no signal. We corroborated the Fas expression
pattern determined by in situ hybridization by RT-PCR.
Fas transcripts were detected by RT-PCR in atrial, ventric-
ular, and OFT total RNA from stage 21 to 32 of heart
development (Fig. 2). Two species were detected, subcl-
oned, and sequenced. The smaller species lacks an alterna-
tive exon and codes for the Fas variant that lacks the trans-
membrane domain (secreted Fas) (Ruberti et al., 1996). The
relative abundance of this transcript was invariant at 1:24
ratio to the alternative exon-included transcript in all regions
of the heart throughout development.
Forced expression of FasL induces PCD
Recombinant replication-defective adenovirus expressing
FasL (AdFasL1), or control adenovirus (AdGFP), was
injected into the pericardial space of stages 15–18 chick
embryos in ovo. We previously showed that this method ofasL1 was injected into the pericardial space of stages 17–18 chick embryos.
very using a lysosomal marker (LTR, Molecular Probes) of PCD. In control
the base of the OFT of the stage 23 embryo. In a stage-matched embryo
E) ventricles, and (F) atria. In section, the LTR particles are observed to be
order of LTR positive and negative cells, representing the distal edge of the
Abbreviations are as in Fig. 1. avj, atrio-ventricular junction. Scale bar in A
Fig. 4. Caspase activities during normal heart development and after forced
FasL expression. Heart homogenates were reacted against DEVD-AFC
(Caspase-3,7 substrate) or IETD-AFC (Caspase-8 and Granzyme substrate).
Release of AFC was measured over 5 h by spectrofluorometry and
calibrated against a standard curve of free AFC. In A, activity from OFT,
atrial, and ventricular homogenates from stage 22 to 32 embryos is shown.
In B, activity from total heart homogenates of embryos transduced with
AdFasL1 or AdGFP (control) is shown. Hearts were collected 8–48 h after
viral transduction (stages 20–25), pooled, and assayed for Caspase
activities. In A and B, each point represents the activity measured from
two separate samples of 6–12 pooled tissues measured in duplicate. With
few exceptions, Caspase activities measured in control atrial or ventricular
homogenates were less than 5 nmol Ag1 h1 (not shown).
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nous protein in the cardiomyocytes of the chick embryo
(Fisher and Watanabe, 1996). Eggs were incubated for an
additional 8–48 h and then assayed for indicators of PCD.
At 15 h after injection of recombinant adenovirus, there was
no difference in the incidence of PCD between control and
experimental embryos as detected by LTR staining (n = 3
each, not shown). At 24 (Fig. 3), 36, and 48 h (not shown)
after administration of AdFasL1, the number of LTR par-
ticles was markedly increased in the atria, ventricles, and
OFT as compared to stage-matched embryos injected with
AdGFP. In control embryos at stage 22, corresponding to
the 24 h time point, there were LTR particles at the base of
the OFT and few or none in the atria and ventricles (Figs.
3A,D). In the AdFasL1 stage-matched control embryos,
LTR particles were abundant in whole mount in the atria,
ventricles and OFT (Figs. 3B,C). LTR staining abruptly
ends within the distal OFT myocardium (Fig. 3B, arrow),
beyond which recombinant adenovirus does not penetrate
with pericardial injections (Fisher and Watanabe, 1996). In
cross-section, 50–100 LTR particles/section were present in
the compact layer of the ventricular myocardium (Figs.
3E,F), atrial myocardium (Fig. 3F), and OFT myocardium
(not shown). Increased prevalence of LTR particles was
observed in 4/4 AdFasL hearts at 24 h, 2/3 hearts at 36 h,
and 4/5 hearts at 48 h. The number of LTR particles were
similar in uninjected embryos and those injected with the
control (AdGFP) recombinant replication-defective adeno-
virus (data not shown).All of the embryos transduced with
FasL were viable at these early time points, as judged by the
presence of a beating heart.
The high prevalence of lysosomes indicated by LTR in
the experimental heart myocardium suggested that AdFasL1
induced PCD. Adjacent sections of these same hearts were
assayed for chromosomal fragmentation, a second marker of
PCD, using the TUNEL assay. The prevalence and positions
of TUNEL positive cells in the atrial, ventricular, and OFT
myocardium of AdFasL1-transduced embryos correlated
well with the LTR staining (data not shown), as we
previously reported for normal heart development
(Schaeffer et al., in press). Thus, forced expression of a
death (FasL) ligand activates the program of cell death in
atrial, ventricular, and OFT cardiomyocytes.
Caspase activity in normal development and after forced
expression of FasL
We next sought to determine if forced expression of FasL
resulted in activation of Caspases, enzymes that initiate and
execute the program of cell death. Ligand binding to death
receptors may result in the formation of a complex of death
domain containing molecules, activation of the initiator
Caspase-8, and subsequent activation of executioner Cas-
pases including Caspase-3. Embryonic cardiac tissue homo-
genates were incubated with several substrates each with
differing target Caspase specificities (Thornberry et al.,1997): DEVD-AFC (Caspase-3,7), IETD-AFC (Caspase-
8,Granzyme), and LEHD-AFC (Caspase-9). The release of
AFC was indicated by an increase in fluorescence and
calibrated against the fluorescence of free AFC. We first
examined the stage dependence of Caspase activities in the
different heart chambers during normal development. Ac-
tivity against DEVD in control embryo OFT increased from
4.4 nmol Ag1 h1 at stages 21–23 (at the beginning of
apoptosis) to 10–15 nmol Ag1 h1 from stage 26 to 32
(Fig. 4A), at the peak of apoptosis in the OFT. This two- to
threefold increase in activity in OFT homogenates during
Fig. 5. Morphology of a AdGFP (control) heart at stage 35. The heart is
shown (A) from the front in whole mount and (B,C) H&E-stained sections
in a frontal plane with respect to the heart. An anterior section (B) shows
the right ventricular connection with the pulmonary artery. A more posterior
section (C) shows the left ventricular connection with the aorta angling to
the right. In D, a higher magnification of the ventricular apical myocardium
is shown. Scale bars = 1 mm in A; 0.8 mm in B; 1.2 mm in C; 0.2 mm in D.
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atrial or ventricular homogenates (data not shown), was
consistent with our previous study (Watanabe et al., 1998).
Interestingly, significant activity against IETD was present
in OFT homogenates at early stages (21–23), just before or
at the initial stage of apoptosis in this tissue, at a time when
activity against DEVD was minimal (Fig. 4A). Activity
against IETD was present in OFT homogenates from stage
21 to 32, with a peak in activity at stages 31–32 of 47.8
nmol Ag1 h1, corresponding to the stages of intense
apoptosis in the OFT myocardium. Modest activity against
IETD was detected in the stages 21–23 atrial and ventric-
ular homogenates. No significant activity against IETD was
detected in atrial and ventricular homogenates beyond these
stages (data not shown). No significant activity against
LEHD (Caspase-9) was detected in any of the homogenates
(data not shown).
We next examined the Caspase activities in total heart
homogenates of hearts transduced with AdFasL1 or control
adenovirus. Activity against IETD was detected at high
levels as early as 8 h after transduction with AdFasL1
(Fig. 4B). The activity against IETD of 24.6 nmol Ag1
h1 in the AdFasL1 hearts was several-fold higher than in
stage-matched controls. The activity against IETD declined
from 8 to 48 h after transduction with AdFasL1. Activity
against DEVD was also present in hearts transduced with
AdFasL1 as early as 8 h after viral transduction. Activity
against DEVD was maintained at a high level for up to 48
h after viral transduction. In the control total heart homo-
genates activity against DEVD was low throughout the 48-
h time course of these experiments.
Effect of forced expression of FasL on cardiac
morphogenesis
To determine what effect dysregulated apoptosis may
have on cardiac morphogenesis, embryos injected with
AdFasL were incubated to stages 33–35 (approximately 7
days). During normal development, the apoptosis-dependent
remodeling of the OFT and the transition to a dual circula-
tion is largely complete by these stages. The number of
embryos that were viable at the endpoint in these experi-
ments was significantly less in the AdFasL1 group (7/24,
30%) compared to those transduced with the control AdGFP
virus (13/17, 76%) or uninjected embryos (3/4, 75%). The
morphologies of 4/7 of the AdFasL1 hearts were markedly
abnormal. Each of the abnormal embryos had defects in the
OFT in which both the aorta and pulmonary artery
connected to the right ventricle (Figs. 6A,C; compare with
control in Fig. 5). The aorta and PA were aligned side-by-
side in a parallel manner instead of their normal spiral
relationship. In 3/4 abnormal embryos, the Ao originated
from the RV to the right of the PA, thus representing double-
outlet right ventricle with transposition of the aorta. In the
fourth embryo, the Ao was directly posterior to the PA. In
each of these embryos the Ao and PA connected directly tothe ventricle, and the aortic and pulmonic semilunar valves
were at the same level, consistent with the elimination of the
myocardial infundibulum that normally elevates the pul-
monic valve and connects the RV to the PA. The semilunar
valves of these hearts appeared to be relatively normal with
thin leaflets. The septum separating the Ao and PA was
intact, indicating that the effect of AdFasL1 on OFT rotation
had not affected septation distal to the semilunar valves nor
the valves themselves.
Morphological abnormalities were also observed in the
other cardiac structures. Regions of the right and left
ventricular myocardium were thinned (Figs. 6C–E) as
compared to controls (Figs. 5B–D). These hearts also
exhibited abnormal structures over the ventricles that were
filled with blood in whole mount (Figs. 6A,B, arrows). In
cross-section, these structures were in the epicardial region
of the heart and in some instances connected with the lumen
of the ventricle (Fig. 6E, arrows). These structures could
represent aneurysmal dilatation of the thinned ventricular
wall or aberrant vascular structures. A large posterior VSD
was present in all of the abnormal hearts (Fig. 6D), and in
Fig. 7. Structural abnormalities in AdFasL2 hearts at stage 35. (A) Frontal
and (B) transilluminated frontal view of an AdFasL2 heart. The outflow
structures are to the right and the inlet structures (atria) to the left, indicating
a failure of the counterclockwise rotation of the cardiac structures. In A, a
diminutive vessel at the abnormally constricted junction of the OFT and
ventricle is evident (arrow). The right ventricle is enlarged. In B,
transillumination shows the common origin of the great vessels from the
RV and a large VSD. (C,D) In frontal section of another heart, the double-
outlet right ventricle/double-inlet left ventricles arrangement and VSD are
evident. As in AdFasL1, the Ao is to the right of the PA (transposed). The
semilunar valves are globular. All four valves are in the same horizontal
plane with fibrous continuity between them. The atrial septum is intact. In
(E), at higher magnification, the ventricular myocardium free wall appears
normal. Scale bar = 0.8 mm for A–B; 0.5 mm in C–D; 0.2 mm in E.
Fig. 6. Structural abnormalities in an AdFasL1 heart at stage 35. (A) In a
frontal view in whole mount, the two great vessels are side-by-side, with
the aorta to the right of the PA (transposed). (B) In the right lateral view,
multiple abnormal blood containing structures (arrow) are evident on the
surface of the heart. In an anterior frontal section (C), the Ao and PA are
side-by-side originating from the RV without an infundibular stalk. In a
posterior section (D), a large VSD is evident (arrow). (E) At higher
magnification, the aberrant vascular structures are evident. One arrow
points to a vessel filled with red blood cells, while the second arrow points
to a lumen that empties into the ventricular cavity. The ventricular wall is
also generally thinner than normal. Scale bar = 1 mm for A–D; 0.2 mm
for E.
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the VSD. In contrast, the atrial septum appeared intact. Also
notable was a change in heart dimensions, with an increase
in the width-to-length ratio of the ventricles and blunted
apices in the AdFasL1 hearts.
Since transduction with the AdFasL1 activated PCD in
myocytes throughout the heart, it was not possible to assess
the extent to which the morphological defects were primary
or secondary effects. We therefore infected embryonic
chicks with a different adenovirus expressing FasL
(AdFasL2) to target its expression to the OFT cardiomyo-
cytes. This resulted in severe cardiac defects in 3/12
embryos that survived to stage 35, and early embryonic
demise in 12/24 embryos. As was observed with AdFasL1,
the subpulmonic myocardial infundibulum was absent or
greatly reduced (Figs. 7A–D). Thus, the pulmonic valve
was in the same horizontal plane as the atrio-ventricular and
aortic valves, with fibrous continuity between them. The
great vessels ascended parallel to each other from the
ventricles, instead of in their usual spiral arrangement. In
addition, the aorta was abnormally positioned anterior and
to the right of the pulmonary artery, instead of its usual
origin to the left and posterior to the PA. This vessel wasidentified as the aorta by (1) its connection to the systemic
circulation and (2) the coronary arteries originating from its
base (Fig. 7A, arrow). Both great vessels originated from the
RV, with the PA overriding the ventricular septum to
partially arise from the LV as well. Both atria connected
to the left side of the heart (the LV), and both great vessels
connected predominantly to the right side of the heart, that
is, double-inlet left ventricle and double-outlet right ventri-
cle morphology. This resembles the embryonic configura-
tion at stage 25, before the counterclockwise rotation that
aligns the inlet and outlet structures. A large posterior
ventricular septal defect was also present, most likely due
to the malalignment of the ventricular septum with the OFT
septum. The semilunar valves were also abnormal, appear-
ing globular resembling primitive ridges of endocardium as
compared to control and AdFasL1 embryos. The thinned
leaflet structure was absent. The general tissue structure of
the ventricles appeared normal, but the ventricular chambers
were dilated, likely secondary to the hemodynamic effects
of the OFT defects. Of note, the aberrant structures evident
on the surface of the ventricles of embryos infected with
Fig. 8. Model of effect of AdFasL on embryonic OFT remodeling. (A) The
single circuit heart of the stage 24 (ED5) embryo in the primitive d-loop has
the atria to the left and the OFT to the right of the forming ventricles. The
OFT myocardium (red) is nearly equal in length to the ventricles. The OFT
endocardial cushions that will give rise to the valves are colored tan. (B)
OFT remodeling is nearly complete in the stage 35 embryo. The OFT
myocardium has shortened and forms the infundibular connection of the RV
to the PA. The Ao has rotated to a posterior position where it directly
connects to the LV with no substantial muscular connection. The great
vessels spiral around each other. The endocardial cushions have been
sculpted into semilunar valves with thin leaflets. (C) Hearts transduced with
AdFasL2 have an absent or greatly reduced infundibulum connecting the
great vessels to the ventricles. There has been an apparent failure of the
posterior rotation of the aorta, so that the Ao and PA are side-by-side and
connect to the RV. The semilunar valves were abnormal in position and
incomplete in development. Thin valve leaflets failed to form. There also is
a large VSD, and failure of the OFT structures to assume their usual central
location between the atria and ventricles, resulting in double-inlet left
ventricle (not shown). AdFasL1 hearts display a similar range of OFT
defects and in addition had significantly abnormal ventricular structures
(not illustrated in this diagram). This figure was modified from a figure
previously published in Rothenberg et al., 2003. Sculpting the cardiac
outflow tract. Birth Defects Res. (Part C) 69, 38–45. Copyright Wiley-Liss.
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AdFasL2, nor was the ventricular myocardium thinned
(Fig. 7E).Discussion
Regulation of PCD
The triggering of the program of cell death must be
highly regulated, as the fortuitous activation of this programin embryonic cells could be catastrophic for the develop-
ment of the embryo. On the other hand, removal of cells by
PCD is a primary mechanism by which tissues are sculpted,
or entirely eliminated, during development (reviewed in
Fisher et al., 2000; Jacobson et al., 1997; van den Hoff et
al., 2000). In the current study, we show that embryonic
atrial, ventricular, and OFT cardiomyocytes are competent
to execute PCD in response to a death ligand. Thus, from
the early stages of heart development, all cardiomyocytes
are endowed with the machinery needed to execute the PCD
in response to a death ligand. Consistent with this obser-
vation, Fas transcripts were detected by in situ hybridization
in all of the embryonic cardiac tissues during this period of
development. In contrast, a study by French et al. (1996)
did not detect Fas transcripts in the E16.5 and E18.5 mouse
heart ventricle. However, their in situ hybridization assay
did not use signal amplification as in the current study, so
that their sensitivity was much lower. The same study using
the RNase protection assays detected Fas transcripts in the
adult mouse heart and almost all adult tissues examined.
The ability of FasL to activate PCD was not tested in the
study by French et al. Using a transgenic approach to force
FasL expression in the mouse heart under the control of the
alpha-myosin heavy chain promoter, Nelson et al. (2000)
did not observe cardiomyocyte PCD in the neonatal heart
although Fas mRNA and protein were present. Prenatal
stages of heart development were not examined, but there
was no apparent effect on heart development in these
experiments. One simple explanation for the difference
between the current study and that of Nelson et al. could
be a difference between mouse and chick heart develop-
ment. Another potential explanation is a difference in the
level of expression of the death ligand when transiently
expressed from a viral promoter (this study) vs. from a
tissue-specific promoter in transgenic mice. Adult cardio-
myocytes and other cells have been shown to vary in their
relative sensitivity to the Fas death ligand (Hayakawa et al.,
2002; reviewed in Curtin and Cotter, 2003). Further study is
required to determine if the regulated expression of down-
stream signaling and regulatory proteins [e.g., Fas-associ-
ated death domain (FADD) and Fas ligand inhibitory
protein (FLIP)] influences the sensitivity of embryonic
cardiomyocytes to potential triggers of PCD. The difference
between our results compared to the transgenic model could
also be due to the acute exposure to the death ligand in this
study vs. the chronic exposure in the mouse transgenic
model.
The ability of ectopically expressed FasL to induce
apoptosis in the developing heart raises the question as to
the role of death receptors and their ligands during normal
heart development. In the developing rabbit lung, alveolar
epithelial cell apoptosis coincided with the appearance of
the Fas death ligand, while the Fas receptor was constitu-
tively expressed (De Paepe et al., 2000). We have not been
able to detect expression of the Fas ligand protein in the
developing chick or mouse heart (data not shown). Evidence
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development comes from gene inactivation studies. Mice
with spontaneous mutations of the Fas ligand (gld) or Fas
(lpr), or targeted mutations of Fas (Adachi et al., 1995),
develop normally and subsequently develop lymphoproli-
ferative disease. This might suggest that the function for the
widespread expression of Fas during heart development is to
eliminate cells under duress in pathological situations.
Alternatively, mutations in Fas/FasL possibly do not pro-
duce a noticeable developmental phenotype due to compen-
sation from redundant members of these gene families, with
at least six mammalian death ligand genes and cognate
receptors identified (reviewed in Ashkenazi and Dixit,
1999). Support for a role for the extrinsic (ligand-depen-
dent) pathway of PCD in normal heart development comes
from the embryonic lethal phenotype in mice with inacti-
vation of Caspase-8 (Varfolomeev et al., 1998) or Fas-
associated death domain (FADD) (Yeh et al., 1998) genes,
each of which are downstream of Fas. These mice die before
E11.5 and display a dilated cardiac phenotype, but it has yet
to be shown that the phenotype results from a failure of
death ligand induced developmental PCD within or beyond
the heart.
In summary, Fas is expressed throughout the embryonic
chick heart, and all of the cardiomyocytes are competent
to execute the PCD when challenged with Fas death
ligand. This suggests that the unique high prevalence of
PCD in the chick OFT cardiomyocytes is due to their
receiving a signal that the other cardiomyocytes do not. In
another study, we have provided evidence that this signal
is myocardial hypoxia specific to the OFT (paper in
review). Hypoxia may trigger apoptosis through the in-
trinsic (mitochondrial/Apaf-1/Caspase-9) pathway (Kuba-
siak et al., 2002; Regula et al., 2002), or through the up-
regulation of Fas and induction of Fas ligand expression
(Lee et al., 2003; Tanaka et al., 1994). The questions as to
which pathway(s) is operative during normal developmen-
tal PCD-dependent remodeling of the OFT and which
death ligand/receptors may be involved require further
study.
Apoptosis and cardiac morphogenesis
The remodeling of the embryonic cardiac OFT in the
transition to a dual circulation is a complex process that
involves multiple processes and cell types (see model, Fig.
8). We previously showed coincidence in the shortening of
the OFT myocardium and posterior rotation of the aorta
with removal of OFT cardiomyocytes by PCD (Watanabe et
al., 1998). We also showed using adenoviral expressed
LacZ or GFP to follow the cell fates that the remaining
OFT cardiomyocytes are located within the subpulmonic
myocardial infundibulum of the four-chambered avian
heart. In the current study, we show that triggering preco-
cious and widespread PCD of the OFT cardiomyocytes
results in the absence of a myocardial infundibular structureconnecting the RV to the PA in a subset of embryos. This
supports the cell fate analyses and provides corroborating
evidence that the subpulmonic infundibulum derives from
the embryonic OFT myocardium. In addition, there
appeared to be a defect in the rotation of the aorta to its
normal posterior position in the affected hearts. Instead the
aorta and pulmonary artery were in a side-by-side config-
uration and connected to the RV, that is, DORV with
transposition of the aorta. The results of these PCD gain-
of-function experiments complement results from our pre-
vious PCD loss-of-function experiments (Watanabe et al.,
2001). In those experiments, adenoviral-mediated forced
expression of the X-linked Inhibitor of Apoptosis Protein
(XIAP), or treatment with the peptide Caspase antagonists
zVAD-fmk or DEVD-CHO, blocked PCD and caused an
excessively long subpulmonic infundibulum. In addition,
there was also apparent failure in the posterior rotation of
the aorta, as evidenced by the DORV with transposition of
the aorta morphology. How OFT cardiomyocyte PCD may
drive rotation of the aorta to its posterior position was
suggested by our more recent analysis of PCD in the
developing chick embryo in whole mount (Schaeffer et
al., in press). We observed dynamic stage-dependent pat-
terns of PCD within the OFT myocardium, with PCD
localized to the subaortic myocardium as the aorta dropped
down and behind the PA from stages 28 to 31. Thus, we
propose that disrupting this process either by ectopic and
diffuse activation of PCD in the OFT myocardium with
AdFasL, or by inhibiting PCD (Watanabe et al., 2001),
results in the malrotation of the aorta. Interestingly, Yelbuz
et al. (2002) showed that neural crest ablation results in a
shortened OFT myocardium and malalignment defects with
dextroposition of the aorta. This suggests that a variety of
perturbations of the OFT myocardium may result in mala-
lignment defects of the great vessels. It is unlikely that
neural crest ablation causes malalignment defects through
an effect on OFT myocardial PCD, as we previously
showed that the prevalence of PCD in the OFT myocardi-
um is not reduced in embryos in which the cardiac neural
crest has been ablated (Rothenberg et al., 2002). Cardio-
myocytes from the OFT have also been suggested to
migrate into the OFT mesenchyme to form a portion of
the interventricular septum in a process termed myocardi-
alization (van den Hoff et al., 1999). It is possible that the
VSDs observed in the current study result from a defect in
this process. However, this requires further study as it is
also possible that the VSDs result from the misalignment of
the vessels and ventricles. The morphological defects
described in this study were present in a minority of hearts
while activation of PCD occurred in the majority of hearts
exposed to AdFasL. This suggests that the developing heart
may be able to compensate for a certain level of cell death
or myocardial loss. It is also possible that the morpholog-
ical analyses underestimate the incidence of heart defects,
as minor abnormalities in ventriculo-arterial connections or
cardiac structures may not have been detected.
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targeted to the OFT myocardium resulted in a failure of
the counter-clockwise rotation of the chambers of the heart,
so that the heart remained in its primitive looped configu-
ration, with the atria to the left and the OFT to the right of
the ventricles. It is possible that the sudden removal of the
OFT myocardium by ectopic FasL expression prevents the
transmission of forces that drive the OFT to its central
position between the atria and ventricles. This morphology
was not observed in hearts where PCD was triggered in all
chambers, possibly due to the matched cell killing in all
chambers versus restricted to the OFT compartment, or
perhaps to differences in the intensity of cell killing. Hearts
in which PCD was triggered in the ventricles also had
relatively large vascular structures on the surface of the
ventricles that in some instances connected to the lumen of
the ventricles. An explanation for the development of these
structures is currently lacking. One possibility is that the
disruption of the OFT myocardium prevents the formation
of the coronary vessels in the OFT and vascular structures
are thus formed ectopically. However, an argument against
this hypothesis is that these aberrant vascular structures
were not observed when PCD was only triggered in the
OFT. An alternative explanation is that the PCD of the
ventricular myocytes somehow triggers a vasculogenic
response. In another study, we have shown that during
normal development, cardiomyocyte PCD and vasculogen-
esis are co-incident in the OFT (Rothenberg et al., 2002 and
paper in review). Whether myocyte PCD may trigger a
vasculogenic response requires further investigation.
In conclusion, we have shown through PCD gain-of-
function experiments that the temporally and spatially
restricted elimination of OFT cardiomyocytes is required
for the proper formation of the ventriculo-arterial connec-
tions. Interference with this process results in malalignment
defects in the OFT with the aorta transposed and side-by-
side with the pulmonary artery. Malalignment defects are a
significant component of congenital human conotruncal
defects, which as a group account for approximately 20%
of all congenital human heart anomalies. It will be of
interest to determine if PCD-dependent remodeling of the
OFT is a target of environmental agents and genetic defects
(Ferencz et al., 1997) that are associated with human heart
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